Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: ... https://t.co/Ykq1n3g3pu
RT @almucastro01: Tratamiento multifactorial y no glucocéntrico mejora la supervivencia en DM2: https://t.co/9lj6DBLb2U
RT @Cristob_Morales: https://t.co/zdyV3DynME 21ańos después d la intervención multifactorial STENO2 en personas con DM2+microalb @cristinat…
RT @Cristob_Morales: https://t.co/zdyV3DynME 21ańos después d la intervención multifactorial STENO2 en personas con DM2+microalb @cristinat…
RT @almucastro01: Tratamiento multifactorial y no glucocéntrico mejora la supervivencia en DM2: https://t.co/9lj6DBLb2U
RT @almucastro01: Tratamiento multifactorial y no glucocéntrico mejora la supervivencia en DM2: https://t.co/9lj6DBLb2U
RT @almucastro01: Tratamiento multifactorial y no glucocéntrico mejora la supervivencia en DM2: https://t.co/9lj6DBLb2U
RT @almucastro01: Tratamiento multifactorial y no glucocéntrico mejora la supervivencia en DM2: https://t.co/9lj6DBLb2U
RT @almucastro01: Tratamiento multifactorial y no glucocéntrico mejora la supervivencia en DM2: https://t.co/9lj6DBLb2U
RT @Cristob_Morales: https://t.co/zdyV3DynME 21ańos después d la intervención multifactorial STENO2 en personas con DM2+microalb @cristinat…
RT @almucastro01: Tratamiento multifactorial y no glucocéntrico mejora la supervivencia en DM2: https://t.co/9lj6DBLb2U
RT @Cristob_Morales: https://t.co/zdyV3DynME 21ańos después d la intervención multifactorial STENO2 en personas con DM2+microalb @cristinat…
RT @Cristob_Morales: https://t.co/zdyV3DynME 21ańos después d la intervención multifactorial STENO2 en personas con DM2+microalb @cristinat…
RT @Cristob_Morales: https://t.co/zdyV3DynME 21ańos después d la intervención multifactorial STENO2 en personas con DM2+microalb @cristinat…
RT @almucastro01: Tratamiento multifactorial y no glucocéntrico mejora la supervivencia en DM2: https://t.co/9lj6DBLb2U
RT @almucastro01: Tratamiento multifactorial y no glucocéntrico mejora la supervivencia en DM2: https://t.co/9lj6DBLb2U
RT @Cristob_Morales: https://t.co/zdyV3DynME 21ańos después d la intervención multifactorial STENO2 en personas con DM2+microalb @cristinat…
RT @Cristob_Morales: https://t.co/zdyV3DynME 21ańos después d la intervención multifactorial STENO2 en personas con DM2+microalb @cristinat…
RT @Cristob_Morales: https://t.co/zdyV3DynME 21ańos después d la intervención multifactorial STENO2 en personas con DM2+microalb @cristinat…
RT @Cristob_Morales: https://t.co/zdyV3DynME 21ańos después d la intervención multifactorial STENO2 en personas con DM2+microalb @cristinat…
RT @Cristob_Morales: https://t.co/zdyV3DynME 21ańos después d la intervención multifactorial STENO2 en personas con DM2+microalb @cristinat…
Multifactorial intervention in type 2 #diabetes patients may prolong life and delay #cardiovascular incidents. https://t.co/FIDsVujsX3 #T2D https://t.co/MiUxZOXwrl
RT @DMGParisV: #LectureDeLaSemaine Une prise en charge multi-facorielle du diabète plus efficace qu'une prise en charge centrée... https://…
RT @DMGParisV: #LectureDeLaSemaine Une prise en charge multi-facorielle du diabète plus efficace qu'une prise en charge centrée... https://…
#LectureDeLaSemaine Une prise en charge multi-facorielle du diabète plus efficace qu'une prise en charge centrée... https://t.co/X3b96XXT0l
Years of life gained by multifactorial intervention in patients with #type2diabetes mellitus and #microalbuminuria https://t.co/NYphaEKdsL
RT @DiabetologiaJnl: Years of life gained by multifactorial intervention in patients with #type2diabetes mellitus and #microalbuminuria htt…
Years of life gained by multifactorial intervention in patients with #type2diabetes mellitus and #microalbuminuria https://t.co/NYphaEsC4b
Gaede (2016) https://t.co/BCFrEuvZjD on Steno-2 RCT followup at 21 years. Good intensive therapy => better patient… https://t.co/GW8CWH6K9K
Intervention addressing multiple risk factors improves outcome in DM. https://t.co/5mMVnKK2Ba
Years of life gained by multifactorial intervention in patients with #type2diabetes mellitus and #microalbuminuria https://t.co/NYphaEKdsL
A Case For Prompt, Intensive Therapy in Type 2 #Diabetes https://t.co/br1ihvLfp0
Nice to see how a team approach to risk factor management improves lifespan in #T2D. #springerlink https://t.co/sZuMkzxiMt
RT @kamleshkhunti: STENO 2 study - at 21 yrs of follow-up, 8 years gained by multifactorial intervention https://t.co/EUJiPpcnRf @ABCDiab @…
【STENO-2試験7.8年追跡:MA尿陽性2型DMへの、生活習慣改善[±血糖低下薬]、RA系阻害薬、ビタミン・ミネラルサプリ [7.8年] で、21年後の死亡、CVイベント有意減少】 Diabetologia https://t.co/f2GZsn5kId 印刷版出来
Great news on #WorldHeartDay. Less CVD in people with #type2 21 yrs after multifactorial intervention #Steno2 study https://t.co/vuzthWXBEL
Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria… https://t.co/hM78YYwoaQ
RT @kamleshkhunti: STENO 2 study - at 21 yrs of follow-up, 8 years gained by multifactorial intervention https://t.co/EUJiPpcnRf @ABCDiab @…
RT @kamleshkhunti: STENO 2 study - at 21 yrs of follow-up, 8 years gained by multifactorial intervention https://t.co/EUJiPpcnRf @ABCDiab @…
RT @kamleshkhunti: STENO 2 study - at 21 yrs of follow-up, 8 years gained by multifactorial intervention https://t.co/EUJiPpcnRf @ABCDiab @…
RT @kamleshkhunti: STENO 2 study - at 21 yrs of follow-up, 8 years gained by multifactorial intervention https://t.co/EUJiPpcnRf @ABCDiab @…
RT @kamleshkhunti: STENO 2 study - at 21 yrs of follow-up, 8 years gained by multifactorial intervention https://t.co/EUJiPpcnRf @ABCDiab @…
RT @kamleshkhunti: STENO 2 study - at 21 yrs of follow-up, 8 years gained by multifactorial intervention https://t.co/EUJiPpcnRf @ABCDiab @…
RT @kamleshkhunti: STENO 2 study - at 21 yrs of follow-up, 8 years gained by multifactorial intervention https://t.co/EUJiPpcnRf @ABCDiab @…
STENO 2 study - at 21 yrs of follow-up, 8 years gained by multifactorial intervention https://t.co/EUJiPpcnRf @ABCDiab @LDC_tweets
RT @DiabetologiaJnl: Benefits of early and intensified treatment of multiple modifiable risk factors for type 2 #diabetes https://t.co/NYph…
RT @FrederikPersson: Long-term follow-up of the Steno 2 study! From @Stenodiabetes on #springerlink https://t.co/Pj9qwCqoJH
RT @DiabetologiaJnl: Benefits of early and intensified treatment of multiple modifiable risk factors for type 2 #diabetes https://t.co/NYph…
Years of life gained by multifactorial intervention in patients with DM2 and microalb: 21 years follow-up on Steno-2 https://t.co/1BbUlRtIrE
RT @alfonso_casi: Importante ganancia años de vida por intervención intensiva en pacientes con #diabetes mellitus 2 y microalbuminuria http…
RT @alfonso_casi: Importante ganancia años de vida por intervención intensiva en pacientes con #diabetes mellitus 2 y microalbuminuria http…
RT @alfonso_casi: Importante ganancia años de vida por intervención intensiva en pacientes con #diabetes mellitus 2 y microalbuminuria http…
RT @alfonso_casi: Importante ganancia años de vida por intervención intensiva en pacientes con #diabetes mellitus 2 y microalbuminuria http…
RT @alfonso_casi: Importante ganancia años de vida por intervención intensiva en pacientes con #diabetes mellitus 2 y microalbuminuria http…
Importante ganancia años de vida por intervención intensiva en pacientes con #diabetes mellitus 2 y microalbuminuria https://t.co/CjIuekQpkQ
RT @DiabetologiaJnl: Benefits of early and intensified treatment of multiple modifiable risk factors for type 2 #diabetes https://t.co/NYph…
Routine monitoring & then Rx of microalbuminuria critical in DM patients. Too often a forgotten test https://t.co/rN1tvwbG3E @nationallipid
RT @DiabetologiaJnl: Benefits of early and intensified treatment of multiple modifiable risk factors for type 2 #diabetes https://t.co/NYph…
At 21 yrs of f/u STENO2 suggest 7.9 yrs of gain of life with multifactorial intervention in #T2D @DiabetologiaJnl https://t.co/BHcnCOPLWx
RT @DiabetologiaJnl: Benefits of early and intensified treatment of multiple modifiable risk factors for type 2 #diabetes https://t.co/NYph…
RT @DiabetologiaJnl: Benefits of early and intensified treatment of multiple modifiable risk factors for type 2 #diabetes https://t.co/NYph…
RT @JuleenRZierath: 21 yrs follow-up on Steno-2 trial in patients w/type 2 diabetes & microalbuminuria @DiabetologiaJnl @Metabolcenter http…
RT @DiabetologiaJnl: 8yr rise in lifespan&time free from CVD via intensified,multifactorial treatment of T2D+microalbuminuria https://t.co/…
RT @robertiroid: El tratamiento intensivo multifactorial aumenta la sobrevida en los pacientes DM2 I'm reading this on #springerlink https:…
RT @JuleenRZierath: 21 yrs follow-up on Steno-2 trial in patients w/type 2 diabetes & microalbuminuria @DiabetologiaJnl @Metabolcenter http…
RT @JuleenRZierath: 21 yrs follow-up on Steno-2 trial in patients w/type 2 diabetes & microalbuminuria @DiabetologiaJnl @Metabolcenter http…
RT @RensVandeberg: @DiabetesFonds Volledige onderzoek #openaccess toegankelijk via https://t.co/82TtYAFJvA
RT @DiabetologiaJnl: Benefits of early and intensified treatment of multiple modifiable risk factors for type 2 #diabetes https://t.co/NYph…
RT @JuleenRZierath: 21 yrs follow-up on Steno-2 trial in patients w/type 2 diabetes & microalbuminuria @DiabetologiaJnl @Metabolcenter http…
RT @DiabetologiaJnl: Benefits of early and intensified treatment of multiple modifiable risk factors for type 2 #diabetes https://t.co/NYph…
RT @JuleenRZierath: 21 yrs follow-up on Steno-2 trial in patients w/type 2 diabetes & microalbuminuria @DiabetologiaJnl @Metabolcenter http…
RT @DiabetologiaJnl: 8yr rise in lifespan&time free from CVD via intensified,multifactorial treatment of T2D+microalbuminuria https://t.co/…
RT @JuleenRZierath: 21 yrs follow-up on Steno-2 trial in patients w/type 2 diabetes & microalbuminuria @DiabetologiaJnl @Metabolcenter http…
RT @JuleenRZierath: 21 yrs follow-up on Steno-2 trial in patients w/type 2 diabetes & microalbuminuria @DiabetologiaJnl @Metabolcenter http…
RT @JuleenRZierath: 21 yrs follow-up on Steno-2 trial in patients w/type 2 diabetes & microalbuminuria @DiabetologiaJnl @Metabolcenter http…
Steno 2 study: multifactorial, target-driven T/t of T2DM with microalbuminuria shows median 7.9 yrs of gain of life. https://t.co/BBwLT4rN9d
RT @JuleenRZierath: 21 yrs follow-up on Steno-2 trial in patients w/type 2 diabetes & microalbuminuria @DiabetologiaJnl @Metabolcenter http…
21 yrs follow-up on Steno-2 trial in patients w/type 2 diabetes & microalbuminuria @DiabetologiaJnl @Metabolcenter https://t.co/OVaJR5QGMf
@DiabetesFonds Volledige onderzoek #openaccess toegankelijk via https://t.co/82TtYAFJvA
El tratamiento intensivo multifactorial aumenta la sobrevida en los pacientes DM2 I'm reading this on #springerlink https://t.co/opb6Z4Zfgb
RT @DiabetologiaJnl: Benefits of early and intensified treatment of multiple modifiable risk factors for type 2 #diabetes https://t.co/NYph…
RT @DiabetologiaJnl: Benefits of early and intensified treatment of multiple modifiable risk factors for type 2 #diabetes https://t.co/NYph…
RT @DiabetologiaJnl: Benefits of early and intensified treatment of multiple modifiable risk factors for type 2 #diabetes https://t.co/NYph…
8yr rise in lifespan&time free from CVD via intensified,multifactorial treatment of T2D+microalbuminuria https://t.co/NYphaEsC4b @EASDnews
RT @DiabetologiaJnl: Intensified & multifaceted treatment of T2D patients with known vascular damage extends life by ~8 yrs @EASDnews https…
RT @DiabetologiaJnl: Intensified & multifaceted treatment of T2D patients with known vascular damage extends life by ~8 yrs @EASDnews https…
RT @DiabetologiaJnl: Benefits of early and intensified treatment of multiple modifiable risk factors for type 2 #diabetes https://t.co/NYph…